Obesity drug showdown: are two injection forms equal?
NCT ID NCT07382908
First seen Feb 03, 2026 · Last updated May 23, 2026 · Updated 21 times
Summary
This study checks if a new multi-dose pen version of the BGM0504 injection works the same as the single-dose version in overweight or obese adults. About 144 people aged 18-55 with a BMI of 24 or higher will get one shot and have their blood levels measured. The goal is to see if the two forms are bioequivalent, meaning they deliver the same amount of drug into the body.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERWEIGHT , OBESITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hangzhou First People's Hospital
RECRUITINGHangzhou, Zhejiang, 310006, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.